[ad_1] — Completes Planned Elimination of $142.9 Million of Long-Term Debt as Announced in March 2024 — MORRISVILLE, N.C., Aug. 27, 2024 /PRNewswire/ — Pyxus International, Inc. (OTC Pink: PYYX) (“Pyxus,” the “Company,” “we,” or […]
Tag: Inc.
Xenia Hotels & Resorts Announces Timing of Third Quarter 2024 Earnings Release and Conference Call
[ad_1] ORLANDO, Fla., Aug. 27, 2024 /PRNewswire/ — Xenia Hotels & Resorts, Inc. (NYSE: XHR) (“Xenia” or the “Company”) will report financial results for the third quarter 2024 after the market closes on Wednesday, November 6, […]
Envestnet Tops 2024 ‘Wealthies’ Finalists List With Seven Nominations
[ad_1] Recognition Spans ‘All-In-One’ Platforms, Innovation, Direct Indexing, Retirement, and Annuities Showcasing Envestnet’s Comprehensive Solutions and Integrations BERWYN, Pa., Aug. 27, 2024 /PRNewswire/ — Envestnet (NYSE: ENV), a leading provider of integrated technology, data intelligence, and […]
Unlock the Extraordinary and Create Memories with Marriott Bonvoy’s Latest Global Promotion
[ad_1] Marriott Bonvoy members can earn up to 4,000 bonus points on 2+ night stays BETHESDA, Md., Aug. 27, 2024 /PRNewswire/ — This fall promises limitless opportunities to create lasting memories – one of them being […]
Alphyn präsentiert Poster zu den klinischen Ergebnissen von Zabalafin-Hydrogel auf dem European Academy of Dermatology and Venereology Congress 2024
[ad_1] ANNAPOLIS, Md., 27. August 2024 /PRNewswire/ – Alphyn Biologics, Inc., ein im klinischen Stadium befindliches Dermatologieunternehmen, das erstklassige Multi-Target Therapeutics® entwickelt, gab heute bekannt, dass Daten aus seiner klinischen Phase-2a-Humanstudie mit Zabalafin-Hydrogel (AB-101a) bei atopischer Dermatitis […]
